Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02267876 · ClinicalTrials.gov registry record
Longitudinal Clinical Evaluation of the HPV Assay on the BD VIPER LT System With Cervical Specimens
A clinical trial of Human Papillomavirus and Cervical Neoplasms, sponsored by Becton, Dickinson and Company.
- Completed
- Registry status
- 6,730
- Enrollment target
- 20
- Study locations
NCT02267876 is a study of Human Papillomavirus and Cervical Neoplasms that has completed, run by Becton, Dickinson and Company. The registered enrollment target is 6,730 participants, below the 25,521-participant average among 12 other Human Papillomavirus trials with a reported enrollment target (74% lower). The trial reports 20 study locations across 12 states.
The verdict
NCT02267876, a study of Human Papillomavirus and Cervical Neoplasms, has completed, sponsored by Becton, Dickinson and Company.
- COMPLETED
- Registry status
- 6,730 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of the study is to assess the cumulative disease detection of greater than or equal to Cervical intraepithelial neoplasia 2 (CIN2) and greater than or equal to Cervical intraepithelial neoplasia 3 (CIN3) in the subjects over 3 years using the subject's HPV status and cytology status from the BDS-USHPV baseline results
Conditions Studied
Interventions
- PROCEDURE Colposcopy
- DEVICE BD HPV Assay on Viper LT
Study Locations (20)
Florida
- Health Awareness Inc. - Jupiter
- Altus Research - Lake Worth
- Segal Institute for Clinical Research - North Miami
- Miami Research Associates - South Miami
- Comprehensive Clinical Trails, LLC - West Palm Beach
Arizona
- Women's Health Research of Arizona - Phoenix
- Quality of Life Medical & Research Center - Tucson
- Visions Clinical Research - Tucson
Alabama
- University of Alabama - Birmingham
- Mobile OB/GYN - Mobile
Georgia
- Medical Network for Education & Research - Decatur
- Fellows Research Alliance - Savannah - Savannah
California
- Women's Health Care Research Corp. - San Diego
Colorado
- Blueskies Center for Women - Colorado Springs
Illinois
- Women's Health Practice - Champaign
Indiana
- Indiana University - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,730 participants |
| Start Date | 2014-10 |
| Est. Completion | 2019-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02267876
The ClinicalTrials.gov registry entry for NCT02267876 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 6,730 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 25,521-participant average among 12 other Human Papillomavirus trials with a reported enrollment target (74% lower). The listed sponsor is Becton, Dickinson and Company, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Human Papillomavirus appearing as the primary indexed condition, and to 2 interventions - of which Colposcopy is the first listed.
NCT02267876 reports 20 study locations spanning 12 distinct geographic areas - top geographies include Florida, Arizona, Alabama.
Frequently Asked Questions
What is clinical trial NCT02267876 about?
NCT02267876 is a clinical study titled "Longitudinal Clinical Evaluation of the HPV Assay on the BD VIPER LT System With Cervical Specimens". The purpose of the study is to assess the cumulative disease detection of greater than or equal to Cervical intraepithelial neoplasia 2 (CIN2) and greater than or equal to Cervical intraepithelial neoplasia 3 (CIN3) in the subjects over 3 years using the subject's HPV status and cytology status from...
What is the current status of trial NCT02267876?
This trial is currently completed. The enrollment target is 6,730 participants. The study started on 2014-10. Estimated completion is 2019-05.
What conditions does trial NCT02267876 study?
This clinical trial studies the following conditions: Human Papillomavirus, Cervical Neoplasms.
What interventions are being tested in trial NCT02267876?
The interventions under investigation include: Colposcopy (PROCEDURE), BD HPV Assay on Viper LT (DEVICE).
Who is sponsoring clinical trial NCT02267876?
This trial is sponsored by Becton, Dickinson and Company, which has 33 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02267876 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Human Papillomavirus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Provider Recommendation and HPV Vaccination
RECRUITING · NA
-
Evaluation of a Novel Point-of-Care Diagnostic Test for Human Papillomavirus (HPV)
RECRUITING
-
Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)
RECRUITING · Phase 4
-
Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune)
RECRUITING
-
A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers
ACTIVE NOT RECRUITING · Phase 1
-
Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to Therapy
COMPLETED
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.